Viewing Study NCT00511069


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-04 @ 5:34 AM
Study NCT ID: NCT00511069
Status: COMPLETED
Last Update Posted: 2008-11-24
First Post: 2007-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia
Sponsor: University of Bologna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module